Market closed
Estrella Immunopharma Inc./$ESLA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
Ticker
$ESLA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
ISIN
US2975841048
Website
ESLA Metrics
BasicAdvanced
$42M
-
-$0.24
0.44
-
Price and volume
Market cap
$42M
Beta
0.44
52-week high
$1.25
52-week low
$0.73
Average daily volume
74K
Financial strength
Current ratio
0.547
Quick ratio
0.306
Total debt to equity
2.783
Management effectiveness
Valuation
Price to book
292.12
Price to tangible book (TTM)
292.12
Price to free cash flow (TTM)
-6.802
Growth
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Estrella Immunopharma Inc. stock?
Estrella Immunopharma Inc. (ESLA) has a market cap of $42M as of May 10, 2025.
What is the P/E ratio for Estrella Immunopharma Inc. stock?
The price to earnings (P/E) ratio for Estrella Immunopharma Inc. (ESLA) stock is 0 as of May 10, 2025.
Does Estrella Immunopharma Inc. stock pay dividends?
No, Estrella Immunopharma Inc. (ESLA) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Estrella Immunopharma Inc. dividend payment date?
Estrella Immunopharma Inc. (ESLA) stock does not pay dividends to its shareholders.
What is the beta indicator for Estrella Immunopharma Inc.?
Estrella Immunopharma Inc. (ESLA) has a beta rating of 0.44. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.